בונדורמין
rafa laboratories ltd - brotizolam - טבליה - brotizolam 0.25 mg - brotizolam - brotizolam - treatment of insomnia.
ברוטיזולאם טבע 0.25 מג
teva israel ltd - brotizolam - טבליה - brotizolam 0.25 mg - brotizolam
בונדורמין
rafa laboratories ltd - brotizolam - טבליה - brotizolam 0.25 mg - brotizolam
ברוטיזולאם טבע 0.25 מ"ג
teva pharmaceutical indust.ltd - brotizolam 0.25 mg - tablets - brotizolam - for the treatment of insomnia.
בוקולאם 2.5 מ"ג
neopharm cure (2005) ltd - midazolam as hydrochloride 2.5 mg - oromucosal solution - midazolam - treatment of prolonged, acute, convulsive seizures in infants, toddlers, children and adolescents (from 3 months to < 18 years). buccolam must only be used by parents/carers where the patient has been diagnosed to have epilepsy. for infants between 3-6 months of age treatment should be in a hospital setting where monitoring is possible and resuscitation equipment is available.
בוקולאם 5 מ"ג
neopharm cure (2005) ltd - midazolam as hydrochloride 5 mg - oromucosal solution - midazolam - treatment of prolonged, acute, convulsive seizures in infants, toddlers, children and adolescents (from 3 months to < 18 years). buccolam must only be used by parents/carers where the patient has been diagnosed to have epilepsy. for infants between 3-6 months of age treatment should be in a hospital setting where monitoring is possible and resuscitation equipment is available.
בוקולאם 7.5 מ"ג
neopharm cure (2005) ltd - midazolam as hydrochloride 7.5 mg - oromucosal solution - midazolam - treatment of prolonged, acute, convulsive seizures in infants, toddlers, children and adolescents (from 3 months to < 18 years). buccolam must only be used by parents/carers where the patient has been diagnosed to have epilepsy. for infants between 3-6 months of age treatment should be in a hospital setting where monitoring is possible and resuscitation equipment is available.
בוקולאם 10 מ"ג
neopharm cure (2005) ltd - midazolam as hydrochloride 10 mg - oromucosal solution - midazolam - treatment of prolonged, acute, convulsive seizures in infants, toddlers, children and adolescents (from 3 months to < 18 years). buccolam must only be used by parents/carers where the patient has been diagnosed to have epilepsy. for infants between 3-6 months of age treatment should be in a hospital setting where monitoring is possible and resuscitation equipment is available
episil ®
perrigo israel agencies ltd - כלל האוכלוסיה - gives relief of pain via mechanical barrier action by a protective film that forms in situ and adheres to the oromucosal surface. intended use of episil® includes oral mucositis that may be caused by chemotherapy or radiotherapy